GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pediatrix Medical Group Inc (NYSE:MD) » Definitions » Ending Cash Position

MD (Pediatrix Medical Group) Ending Cash Position : $104 Mil (As of Sep. 2024)


View and export this data going back to 1959. Start your Free Trial

What is Pediatrix Medical Group Ending Cash Position?

Pediatrix Medical Group's Ending Cash Position for the quarter that ended in Sep. 2024 was $104 Mil.

Pediatrix Medical Group's quarterly Ending Cash Position increased from Mar. 2024 ($8 Mil) to Jun. 2024 ($19 Mil) and increased from Jun. 2024 ($19 Mil) to Sep. 2024 ($104 Mil).

Pediatrix Medical Group's annual Ending Cash Position declined from Dec. 2021 ($387 Mil) to Dec. 2022 ($10 Mil) but then increased from Dec. 2022 ($10 Mil) to Dec. 2023 ($73 Mil).

Pediatrix Medical Group Ending Cash Position Historical Data

The historical data trend for Pediatrix Medical Group's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pediatrix Medical Group Ending Cash Position Chart

Pediatrix Medical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 107.87 1,123.84 387.39 9.82 73.26

Pediatrix Medical Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.18 73.26 8.00 19.40 103.83

Pediatrix Medical Group Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Pediatrix Medical Group's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=9.824+63.434
=73

Pediatrix Medical Group's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=19.402+84.429
=104

Pediatrix Medical Group Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Pediatrix Medical Group's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Pediatrix Medical Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pediatrix Medical Group Inc (NYSE:MD) » Definitions » Ending Cash Position
Comparable Companies
AVAH GRDN USPH BKD PNTG AMN HCSG AGL INNV ASTH HCA SAU:4013 XTER:FRE SZSE:300015 XKLS:5225 THC DVA UHS XTER:FME BKK:BDMS
Traded in Other Exchanges
MD:Mexico PDC:Germany
Address
1301 Concord Terrace, Sunrise, FL, USA, 33323
Website
https://www.pediatrix.com
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment and generates majority of the revenue through neonatology and other pediatric subspecialties.
Executives
Mark S Ordan director, officer: Chief Executive Officer 7315 WISCONSIN AVENUE, SUITE #250 WEST, BETHESDA MD 20814
Moore Mary Ann E officer: EVP Chief ERM/Legal Ops Off 1301 CONCORD TERRACE, SUNRISE FL 33323
James D Swift officer: EVP, Chief Operating Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Laura A Linynsky director 1301 CONCORD TERRACE, SUNRISE FL 33323
C Marc Richards officer: EVP, Chief Financial Officer 7315 WISCONSIN AVENUE, SUITE 250-W, BETHESDA MD 20814
Shirley A Weis director 11621 RESEARCH CIRCLE, GAINESVILLE FL 32615
Sylvia Jean Young director C/O LINCOLN EDUCATIONAL SERVICES CORPORA, 14 SYLVAN WAY, STE. A, PARSIPPANY NJ 07054
Curtis Pickert officer: EVP, Chief Operating Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Lee Wood officer: EVP, Natl & Market Operations 1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Md Medel director, officer: PRES. & CHIEF EXEC. OFFICER 1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Mack Hinson officer: Pres., PDX & OBX Medical Group C/O MEDNAX, INC., 1301 CONCORD TERRACE, SUNRISE FL 33323
John C Pepia officer: Principal Accounting Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Dominic J Andreano officer: Sr.VP,General Counsel & Secy. 1301 CONCORD TERRACE, SUNRISE FL 33323
Nicholas Nikolopoulos officer: EVP Chf Strategy & Growth Offi MEDNAX INC, 1301, SUNRISE FL 33323
Thomas Mceachin director 11621 RESEARCH CIRCLE, ALACHUA FL 32615